Jf. Dorgan et al., THE RELATION OF BODY-SIZE TO PLASMA-LEVELS OF ESTROGENS AND ANDROGENSIN PREMENOPAUSAL WOMEN (MARYLAND, UNITED-STATES), CCC. Cancer causes & control, 6(1), 1995, pp. 3-8
We analyzed data from a cross-sectional study of 107 premenopausal wom
en to evaluated the relations of height, weight, and body mass index (
BMI) with plasma hormone levels. Participants were 20- to 40-year old
women residing in Maryland (United States), whose reported menstrual c
ycle lengths were not more than 35 days and whose measured weights for
height were 85 to 130 percent of 'desirable' based on 1983 Metropolit
an Life Insurance tables. Fasting blood specimens were collected on ea
ch of days 5-7, 12-15, and 21-23 of every participant's menstrual cycl
e and pooled to create follicular, midcycle, and luteal phase samples,
respectively, for analysis. Adjusted for age, taller women had signif
icantly higher follicular-phase plasma-estradiol levels (percent diffe
rence/cm = 1.5, 95 percent confidence interval [CI] = 0.3-2.7, and hea
vier women had significantly lower plasma sex-hormone binding globulin
(SHBG) levels averaged across the menstrual cycle phases (percent dif
ference/kg = -1.2; CI = -1.9-0.6). Body weight within the range studie
d, however, was not related significantly to the concentration of SHBG
-bound estradiol during any phase of the menstrual cycle. The results
of this cross-sectional study suggest a possible mechanism by which he
ight may influence breast cancer risk.